From the rolling green hills of southern Switzerland comes Singota Solutions’ latest announcement: and it’s one that packs a punch. This ever-growing CDMO just unveiled our newest international addition: a cutting-edge, solar-powered, three-floor pharmaceutical storage and logistics facility located in the heart of Balerna, Switzerland.
Perfectly situated near the Swiss-Italian border, this 100,000 square foot site is more than just a pretty face. With over 4,000 pallet positions available for +15-25°C temperature-controlled storage (and plans to add -20°C and +5°C capacity soon), the new Balerna facility is a game-changer for global cold chain operations. Clients looking for scalability, regulatory flexibility, and seamless import/export handling now have a brand-new European hub they can count on.
And it’s not just spacious and strategic – it’s smart. The building is topped with a solar power system that keeps operations sustainable and resilient. What’s more, ur Open Bonded Warehouse status means enhanced compliance and cost efficiencies for high-value goods and life science products, and this Balerna location is fully certified by Swissmedic to handle GDP-compliant activities with precision.
The Balerna facility joins our existing European locations in Basel, Switzerland, and Rovello Porro, Italy, creating a robust, interconnected depot network that supports life sciences clients from early development through commercialization – and everywhere in between. With nearly two decades of operational excellence under our belt, and six years of proven success across Europe, Singota Solutions is continuing to raise the bar for pharmaceutical logistics.
Whether you’re a global biotech, clinical-stage pharma team, commercial manufacturer, or anything in between, Singota’s newly expanded European footprint (including this sparkling Balerna gem) offers the quality, reliability, and agility you need.
Want to learn more or plan your next international move with a partner who makes global distribution look easy? We’re ready when you are.
Read more in the press release below:
